FibroGen (FGEN) Tops Q1 EPS by 15c

FibroGen (NASDAQ: FGEN) reported Q1 EPS of $0.05, $0.15 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $2.74 million versus the consensus estimate of $35.5 million.

For earnings history and earnings-related data on FibroGen (FGEN) click here.

You May Also Be Interested In

• Apollo Global Management (APO) call put ratio 1 call to 6.8 puts a focus on a spreader of 9K contracts January 95 and 135 puts
• Active options: TSLA NVDA AMZN GOOGL AAPL SPCX MSFT NFLX INTC
• Increasing unusual put option volume: OSS CTSH PZZA BFLY CDNS WMB KD DFTX CAN HIVE SOC WYFI SIMO